Lamisil Lotion (Terbinafine Hydrochloride)

Terbinafine, the active ingredient in Lamisil Lotion, blocks the fungal enzyme squalene epoxidase. This inhibition prevents the synthesis of ergosterol, an essential component of the fungal cell membrane, leading to accumulation of squalene and cell death. By targeting this pathway, terbinafine effectively eradicates dermatophytes and other susceptible fungi on the skin.

The specific amount and frequency of application are determined by the prescribing healthcare professional. Typically, a thin layer is applied to the affected area once daily for the duration recommended by the prescriber, which may vary depending on the infection type and severity.

Safety data for terbinafine lotion in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss use with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After receiving the request, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details (including any cold‑chain requirements) and required import documentation.

Lamisil Lotion (allylamine) differs from azole antifungals by targeting squalene epoxidase rather than lanosterol 14α‑demethylase. This distinct mechanism often results in faster fungal clearance and lower rates of resistance for dermatophyte infections. Azoles may be preferred for certain yeasts, while terbinafine is generally favored for dermatophyte‑related skin conditions.

Store Lamisil Lotion at room temperature, ideally below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the cap is tightly closed when not in use. Do not freeze or expose the lotion to extreme temperatures.

Clean and dry the affected skin area before use. Apply a thin, even layer of the lotion to the lesion and a small margin of surrounding skin, gently rubbing it in until it disappears. Wash hands after application unless the hands are being treated. Follow the prescriber’s instructions regarding frequency and treatment duration.

Serious adverse reactions, although rare, include severe allergic responses such as facial swelling, difficulty breathing, widespread rash, Stevens‑Johnson syndrome or toxic epidermal necrolysis. If any of these occur, discontinue use immediately and seek medical attention. Prompt reporting of severe skin reactions is essential.

Individuals with a known hypersensitivity to terbinafine, other allylamine antifungals, or any component of the formulation should avoid using Lamisil Lotion. It is also contraindicated on severely damaged, inflamed or broken skin unless directed by a healthcare professional.